SEARCH

SEARCH BY CITATION

References

  • Calado, R.T. & Young, N.S. (2008) Telomere maintenance and human bone marrow failure. Blood, 111, 44464455.
  • Camitta, B.M., Rappeport, J.M., Parkman, R. & Nathan, D.G. (1975) Selection of patients for bone marrow transplantation in severe aplastic anemia. Blood, 45, 355363.
  • Camitta, B.M., Thomas, E.D., Nathan, D.G., Santos, G., Gordon-Smith, E.C., Gale, R.P., Rappeport, J.M. & Storb, R. (1976) Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood, 48, 6370.
  • Davis, S. & Rubin, A.D. (1972) Treatment and prognosis in aplastic an’mia. Lancet, 1, 871873.
  • Deeg, H.J., O’Donnell, M., Tolar, J., Agarwal, R., Harris, R.E., Feig, S.A., Territo, M.C., Collins, R.H., McSweeney, P.A., Copelan, E.A., Khan, S.P., Woolfrey, A. & Storer, B. (2006) Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood, 108, 14851491.
  • Di Bona, E., Rodeghiero, F., Bruno, B., Gabbas, A., Foa, P., Locasciulli, A., Rosanelli, C., Camba, L., Saracco, P., Lippi, A., Iori, A.P., Porta, F., De Rossi, G., Comotti, B., Iacopino, P., Dufour, C. & Bacigalupo, A. (1999) Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). British Journal of Haematology, 107, 330334.
  • Duarte, L., López Sandoval, R., Esquivel, F. & Sánchez-Medal, L. (1972) Androstane therapy of aplastic anaemia. Acta Haematologica, 47, 140145.
  • Dunn, D.E., Tanawattanacharoen, P., Boccuni, P., Nagakura, S., Green, S.W., Kirby, M.R., Kumar, M.S., Rosenfeld, S. & Young, N.S. (1999) Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Annals of Internal Medicine, 131, 401408.
  • Frickhofen, N. & Rosenfeld, S.J. (2000) Immunosuppressive treatment of aplastic anemia with antithymocyte globulin and cyclosporine. Seminars in Hematology, 37, 5668.
  • Frickhofen, N., Kaltwasser, J.P., Schrezenmeier, H., Raghavachar, A., Vogt, H.G., Herrmann, F., Freund, M., Meusers, P., Salama, A. & Heimpel, H. (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. New England Journal of Medicine, 324, 12971304.
  • Fuhrer, M., Rampf, U., Baumann, I., Faldum, A., Niemeyer, C., Janka-Schaub, G., Friedrich, W., Ebell, W., Borkhardt, A., Bender-Goetze, C. & for the German/Austrian Aplastic Anemia Working, G. (2005) Immunosuppressive therapy for aplastic anemia in children: a more severe disease predicts better survival. Blood, 106, 21022104.
  • Furuhjelm, U. & Eklund, J. (1966) Treatment of aplastic anemia with anabolic steroids and corticosteroids. Annales Paediatriae Fenniae, 12, 8995.
  • Gluckman, E., Devergie, A., Faille, A., Barrett, A.J., Bonneau, M., Boiron, M. & Bernard, J. (1978) Treatment of severe aplastic anemia with antilymphocyte globulin and androgens. Experimental Hematology, 6, 679687.
  • Haak, H.L., Hartgrink-Groenveld, C.A., Ernisse, J.G., Speck, B. & Van Rood, J.J. (1977) Acquired aplastic anaemia in adults. I. A retrospective study of 40 cases: single factors influencing prognosis. Acta Haematologica, 58, 257277.
  • Hormann, A., Berchthold, W., Rhyner, K., Wiedemann-Sigg, C. & Gmur, J. (1984) Prognosis in acquired aplastic anemia. Acta Haematologica, 71, 8189.
  • Li, F.P., Alter, B.P. & Nathan, D.G. (1972) The mortality of acquired aplastic anemia in children. Blood, 40, 153162.
  • Locasciulli, A., Oneto, R., Bacigalupo, A., Socie, G., Korthof, E., Bekassy, A., Schrezenmeier, H., Passweg, J., Fuhrer, M., on the behalf of the Severe Aplastic Anemia Working Party of the European Group for, B. & Marrow, T. (2007) Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation. Haematologica, 92, 1118.
  • Lohrmann, H.P., Kern, P., Niethammer, D. & Heimpel, H. (1976) Identification of high-risk patients with aplastic anaemia in selection for allogeneic bone-marrow transplantation. Lancet, 2, 647650.
  • Maciejewski, J.P., Selleri, C., Anderson, S. & Young, N.S. (1995a) Fas antigen expression on CD34+ human marrow cells is induced by interferon-gamma and tumor necrosis factor-alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood, 85, 31833190.
  • Maciejewski, J.P., Selleri, C., Sato, T., Anderson, S. & Young, N.S. (1995b) Increased expression of Fas antigen on bone marrow CD34+ cells of patients with aplastic anemia. British Journal of Haematology, 91, 245252.
  • Means, Jr, R.T., Krantz, S.B., Dessypris, E.N., Lukens, J.N., Niblack, G.D., Greer, J.P., Flexner, J.M. & Stein, R.S. (1988) Re-treatment of aplastic anemia with antithymocyte globulin or antilymphocyte serum. American Journal of Medicine, 84, 678682.
  • Najean, Y. & Pecking, A. (1979) Prognostic factors in acquired aplastic anemia. A study of 352 cases. American Journal of Medicine, 67, 564571.
  • Nissen, C., Gratwohl, A., Tichelli, A., Stebler, C., Wursch, A., Moser, Y., Dalle Carbonare, V., Signer, E., Buser, M., Ritz, R. & Speck, B. (1993) Gender and response to antilymphocyte globulin (ALG) for severe aplastic anaemia. British Journal of Haematology, 83, 319325.
  • Passweg, J.R., Perez, W.S., Eapen, M., Camitta, B.M., Gluckman, E., Hinterberger, W., Hows, J.M., Marsh, J.C., Pasquini, R., Schrezenmeier, H., Socie, G., Zhang, M.J. & Bredeson, C. (2006) Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplantation, 37, 641649.
  • Risitano, A.M., Maciejewski, J.P., Green, S., Plasilova, M., Zeng, W. & Young, N.S. (2004) In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR [beta]-CDR3 sequencing. The Lancet, 364, 355364.
  • Rosenfeld, S.J., Kimball, J., Vining, D. & Young, N.S. (1995) Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood, 85, 30583065.
  • Rosenfeld, S., Follmann, D., Nunez, O. & Young, N.S. (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. Journal of the American Medical Association, 289, 11301135.
  • Rozman, C., Marin, P., Gra¤ena, A., Nomdedu, B., Montserrat, E., Feliu, E. & Vives-Corron, J.L. (1981) Prognosis in acquired aplastic anaemia. A multivariate statistical analysis of 80 cases. Scandinavian Journal of Haematology, 26, 321329.
  • Sanchez-Medal, L., Gomez-Leal, A., Duarte, L. & Guadalupe Rico, M. (1969) Anabolic androgenic steroids in the treatment of acquired aplastic anemia. Blood, 34, 283300.
  • Scheinberg, P., Wu, C.O., Nunez, O. & Young, N.S. (2008) Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. The Journal of Pediatrics, doi: DOI: 10.1016/j.jpeds.2008.06.004.
  • Scheinberg, P., Nunez, O., Wu, C. & Young, N.S. (2006a) Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. British Journal of Haematology, 133, 606611.
  • Scheinberg, P., Nunez, O. & Young, N.S. (2006b) Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. British Journal of Haematology, 133, 622627.
  • Sloand, E., Kim, S., Maciejewski, J.P., Tisdale, J., Follmann, D. & Young, N.S. (2002) Intracellular interferon-gamma in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood, 100, 11851191.
  • Sloand, E.M., Scheinberg, P., Fenlon, E., Blancato, J., Pfannes, L. & Young, N.S. (2007) Monosomy 7 detected by FISH at disease presentation is a marker for non-response to immunosuppression. Blood (ASH Annual Meeting Abstracts), 110, 506a.
  • Sugimori, C., Chuhjo, T., Feng, X., Yamazaki, H., Takami, A., Teramura, M., Mizoguchi, H., Omine, M. & Nakao, S. (2006) Minor population of CD55−CD59− blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood, 107, 13081314.
  • Takami, A., Nakao, S., Tatsumi, Y., Wang, H., Weihua, Z., Yamazaki, H., Yasue, S., Shiobara, S., Matsuda, T. & Mizoguchi, H. (1999) High inducibility of heat shock protein 72 (hsp72) in peripheral blood mononuclear cells of aplastic anaemia patients: a reliable marker of immune-mediated aplastic anaemia responsive to cyclosporine therapy. British Journal of Haematology, 106, 377384.
  • Te Velde, J. & Haak, H.L. (1977) Aplastic anaemia. Histological investigation of methacrylate embedded bone marrow biopsy specimens; correlation with survival after conventional treatment in 15 adult patients. British Journal of Haematology, 35, 6169.
  • Tichelli, A., Passweg, J., Nissen, C., Bargetzi, M., Hoffmann, T., Wodnar-Filipowicz, A., Signer, E., Speck, B. & Gratwohl, A. (1998) Repeated treatment with horse antilymphocyte globulin for severe aplastic anaemia. British Journal of Haematology, 100, 393400.
  • Tichelli, A., Soci‘, G., Henry-Amar, M., Marsh, J., Passweg, J., Schrezenmeier, H., McCann, S., Hows, J., Ljungman, P., Marin, P., Raghavachar, A., Locasciulli, A., Gratwohl, A. & Bacigalupo, A. (1999) Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. The European Group for Blood and Marrow Transplantation Several Aplastic Anaemia Working Party. Annals of Internal Medicine, 130, 193201.
  • Verma, A., Deb, D.K., Sassano, A., Kambhampati, S., Wickrema, A., Uddin, S., Mohindru, M., Van Besien, K. & Platanias, L.C. (2002) Cutting edge: activation of the p38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia. Journal of Immunology, 168, 59845988.
  • Williams, D.M., Lynch, R.E. & Cartwright, G.E. (1973) Drug-induced aplastic anemia. Seminars in Hematology, 10, 195223.
  • Williams, D.M., Lynch, R.E. & Cartwright, G.E. (1978) Prognostic factors in aplastic anaemia. Clinics in Haematology, 7, 467474.
  • Yagasaki, H., Yoshida, N., Hirano, N., Nishio, N., Hama, A., Wang, Y., Takahashi, Y. & Kojima, S. (2006) Presence of HLA-DR15, a minor PNH clone, or an aplastic anemia-associated autoantibody do not predict a favorable response to immunosuppressive therapy in children with aplastic anemia. Blood (ASH Annual Meeting Abstracts), 108, 984.
  • Young, N.S., Calado, R.T. & Scheinberg, P. (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood, 108, 25092519.